President Donald J.
The European Medicines Agency is taking steps to rethink how certain high-need medicines reach patients, with a new concept paper proposing a more flexible, evidence-based pathway...
In 2025, the psychedelic medicine sector reached a more defined phase of maturity, as Big Pharma entry, late-stage clinical readouts, and incremental regulatory shifts began to...
Last week, the U.S.
Dr. Celia Morgan is one of the UK’s leading figures in ketamine and psychedelic research, especially in the domain of addiction and mental health.
By Jody Chu and James Bunn.
In recent years, the UK has seen a resurgence in interest and investment in psychedelic research, particularly focusing on substances like psilocybin and MDMA.
The past year featured some of Britain’s most significant landmarks in advancing access to psychedelic medicine.
A trend towards the legalization of psychedelic substances for medical use continues across the English-speaking world.
The European Citizens’ Initiative for Psychedelic-Assisted Therapies – launching at the start of 2025 – is aiming to collect one million signatures to urge the European...
